MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Press releases

Displaying 1..10 of 190 - per page Next page
Order by
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. More
A flavonoid derived from citrus fruit has shown tremendous promise for preventing weight gain and other signs of metabolic syndrome which can lead to Type 2 Diabetes and increased risk of cardiovascular disease. More
An HIV/AIDS vaccine developed at The University of Western Ontario is set for the first phase of human trials.

Sumagen Canada today announced it has submitted an Investigational New Drug application to the United States FDA. More
London Health Sciences Centre (LHSC) and Lawson Health Research Institute (Lawson) are pleased to announce a Canadian first in the treatment of lung cancer. On May 13, 2009 surgeon and clinical researcher Dr. Richard Malthaner and oncologist Dr. Edward More
Western virologist Yong Kang's research now at toxicology testing stage, with phase 1 human clinical trials to begin as early as three months from now. More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More
Thanks to the support of The W. Garfield Weston Foundation Dr. Peter Cadieux has an opportunity to improve the wellbeing of people in our community and beyond. More
A first of its kind involving older adults at risk More
Displaying 1..10 of 190 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Biobusiness 2009
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us